Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

被引:2
作者
Michael, Toni J. F. [1 ]
Wright, Daniel F. B. [2 ]
Chan, Jian S. [3 ]
Coleshill, Matthew J. [4 ]
Aslani, Parisa [1 ]
Hughes, Dyfrig A. [5 ]
Day, Richard O. [3 ,6 ]
Stocker, Sophie L. [1 ,6 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sch Pharm, Camperdown, Australia
[2] Univ Otago, Sch Pharm, Dunedin, New Zealand
[3] Univ New South Wales, Fac Med, St Vincents Clin Campus, Sydney, Australia
[4] Univ New South Wales, Black Dog Inst, Fac Med, Randwick, Australia
[5] Bangor Univ, Sch Med & Hlth Sci, Bangor, Wales
[6] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Darlinghurst, Australia
关键词
MEDICATION ADHERENCE; BLOOD-PRESSURE; MANAGEMENT; REGRESSION; DISEASE; CARE;
D O I
10.1002/acr2.11666
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveSelf-monitored point-of-care urate-measuring devices are an underexplored strategy to improve adherence to urate-lowering therapy and clinical outcomes in gout. This study observed patient-led urate self-monitoring practice and assessed its influence on allopurinol adherence, urate control, and health-related quality of life. MethodsPeople with gout (n = 31) and prescribed allopurinol self-monitored their urate concentrations (HumaSens2.0(plus)) at baseline and thereafter monthly for 12 months (3 months per quarter). Adherence to allopurinol was measured using medication event monitoring technology (Medication Event Monitoring System cap). Time spent below the target urate concentration (<0.36 mmol/L) was determined. Health-related quality of life was measured using a survey (EuroQoL EQ-5D-5L). Gout flares were recorded. Two-tailed Spearman correlation and the Wilcoxon matched-pairs signed-rank test (P < 0.05) were used for statistical comparisons. ResultsMost participants were male (94%) and had urate concentrations below the target (74%) at baseline. Overall, seven participants demonstrated repeated periods of "missed doses" (two or fewer allopurinol doses missed consecutively) and "drug holidays" (three or more missed doses). Most participants (94%) persisted with allopurinol. Time spent within the target urate concentration increased 1.3-fold (from 79% to 100%; P = 0.346), and the incidence of gout flares decreased 1.6-fold (from 8 to 5; P = 0.25) in the final quarter compared to that in the first quarter of the study. Health-related quality of life was reduced for participants reporting at least one gout flare (median utility values 0.9309 vs 0.9563, P = 0.04). ConclusionPatient-led urate self-monitoring may support the maintenance of allopurinol adherence and improve urate control, thus reducing the incidence of gout flares. Further research on patient-led urate self-monitoring in a randomized controlled study is warranted.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 50 条
  • [41] Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study
    Oreja-Guevara, Celia
    Meca-Lallana, Jose E.
    Diaz-Diaz, Judit
    Ara, Jose-Ramon
    Perez, Miguel Angel Hernandez
    Gil, Julia Gracia
    Torres, Ana Maria Alonso
    de la Fuente, Belen Pilo
    Ramio-Torrenta, Lluis
    Madueno, Sara Eichau
    Gascon-Gimenez, Francisco
    Casanova, Bonaventura
    Martinez-Yelamos, Sergio
    Valcarcel, Marta Aguado
    Gines, Maria Luisa Martinez
    Montero, Yasmina El Berdei
    Real, Ana Maria Lopez
    Gonzalez-Quintanilla, Vicente
    De Torres, Laura
    Martinez-Rodriguez, Jose Enrique
    Costa-Frossard, Lucienne
    Redondo, Moises Garces
    Fontcuberta, Andres Labiano
    Castellanos-Pinedo, Fernando
    Merino, Juan Antonio Garcia
    Fernandez, Carmen Munoz
    Castillo-Trivino, Tamara
    Meca-Lallana, Virginia
    Martinez, Joaquin Pena
    Rodriguez-Antiguedad, Alfredo
    Gonzalez, Jose Maria Prieto
    Morales, Eduardo Aguera
    Molina, Inmaculada Perez
    Sanchez, Dulce M. Solar
    Varo, Nicolas Herrera
    Sevilla, Raul Romero
    Vicente, Lidia Gomez
    Rio, Jordi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [42] Therapeutic education as a tool to improve patient-reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study
    Villeneuve, Claire
    Rerolle, Jean-Phillipe
    Couzi, Lionel
    Westeel, Pierre-Francois
    Etienne, Isabelle
    Esposito, Laure
    Kamar, Nassim
    Buchler, Mathias
    Thierry, Antoine
    Marquet, Pierre
    Monchaud, Caroline
    TRANSPLANT INTERNATIONAL, 2021, 34 (11) : 2341 - 2352
  • [43] Study protocol for Chronic Obstructive Pulmonary Disease-Sitting and ExacerbAtions Trial (COPD-SEAT): a randomised controlled feasibility trial of a home-based self-monitoring sedentary behaviour intervention
    Orme, Mark
    Weedon, Amie
    Esliger, Dale
    Saukko, Paula
    Morgan, Mike
    Steiner, Michael
    Downey, John
    Singh, Sally
    Sherar, Lauren
    BMJ OPEN, 2016, 6 (10):
  • [44] The Association Between Patient-Reported Self-management Behavior, Intermediate Clinical Outcomes, and Mortality in Patients With Type 2 Diabetes: Results From the KORA-A Study
    Laxy, Michael
    Mielck, Andreas
    Hunger, Matthias
    Schunk, Michaela
    Meisinger, Christa
    Rueckert, Ina-Maria
    Rathmann, Wolfgang
    Holle, Rolf
    DIABETES CARE, 2014, 37 (06) : 1604 - 1612
  • [45] Randomised controlled trial of a psychotherapeutic intervention to improve quality of life and other outcomes in people who repeatedly self-harm: FReSH START study protocol
    Farley, K.
    Copsey, B.
    Wright-Hughes, A.
    Farrin, A.
    Bojke, C.
    McMillan, D.
    Graham, C. D.
    Mattock, R.
    Brennan, C. A.
    Gates, C.
    Martin, A.
    Dowse, A.
    Horrocks, J.
    House, A. O.
    Guthrie, E. A.
    TRIALS, 2024, 25 (01)
  • [46] Effects of self-monitoring physical activity with wearable activity trackers on perceived joint function and health-related quality of life in people with hip and knee osteoarthritis: a secondary analysis of a cluster-randomised clinical trial
    Ostlind, Elin
    Eek, Frida
    Stigmar, Kjerstin
    Hansson, Eva Ekvall
    BMC MUSCULOSKELETAL DISORDERS, 2025, 26 (01)
  • [47] Individual patient-centered target-driven intervention to improve clinical outcomes of diabetes, health literacy, and self-care practices in Nepal: A randomized controlled trial
    Pardhan, Shahina
    Upadhyaya, Tirthalal
    Smith, Lee
    Sharma, Tara
    Tuladhar, Sarita
    Adhikari, Bhojraj
    Kidd, John
    Sapkota, Raju
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [48] Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH)
    Baenziger, Silas
    Weisshaar, Kimmo
    Arokoski, Reetta
    Gerull, Sabine
    Halter, Joerg
    Rovo, Alicia
    Bargetzi, Mario
    Goede, Jeroen S.
    Senft, Yuliya
    Valenta, Sabine
    Passweg, Jakob R.
    Drexler, Beatrice
    ANNALS OF HEMATOLOGY, 2023, 102 (01) : 199 - 208
  • [49] Diabetes Self-Management Education and Medical Nutrition Therapy Improve Patient Outcomes: A Pilot Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions through Retrospective Chart Review
    Marincic, Patricia Z.
    Hardin, Arnie
    Salazar, Maria V.
    Scott, Susan
    Fan, Shirley X.
    Gaillard, Philippe R.
    JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2017, 117 (08) : 1254 - 1264
  • [50] The Healthy Hearts and Kidneys (HHK) study: Design of a 2 x 2 RCT of technology-supported self-monitoring and social cognitive theory-based counseling to engage overweight people with diabetes and chronic kidney disease in multiple lifestyle changes
    Sevick, Mary Ann
    Woolf, Kathleen
    Mattoo, Aditya
    Katz, Stuart D.
    Li, Huilin
    St-Jules, David E.
    Jagannathan, Ram
    Hu, Lu
    Pompeii, Mary Lou
    Ganguzza, Lisa
    Li, Zhi
    Sierra, Alex
    Williams, Stephen K.
    Goldfarb, David S.
    CONTEMPORARY CLINICAL TRIALS, 2018, 64 : 265 - 273